Autopsy report · NCT06622668

NTLA-3001 in Adults with Alpha-1 Antitrypsin Deficiency-Associated Lung Disease

“Clinical trial ITL-3001-CL-101 for the investigational product NTLA-3001 was withdrawn due to prioritization of other Sponsor programs.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 1, Phase 2

Sponsor

Intellia Therapeutics

Sponsor type

Industry

Conditions

Lung Disease; Pulmonary Disease; AATD; Alpha-1 Antitrypsin Deficiency; Alpha-1 Antitrypsin Deficiency-associated Lung Disease

Interventions

Biological NTLA-3001

Participants

0

Sites

1

Countries

New Zealand

Trials that died the same way

• Phase 3 Trial to Evaluate the Efficacy and Safety of DKP21102_B Added on to DKP21102_A Compared With DKP21102_A
  “The clinical trial was withdrawn due to a commercial decision.” (70% match in meaning)
• A Study to Evaluate the Efficacy and Safety of REL-1017 As Adjunctive Treatment of Major Depressive Disorder (MDD)
  “The study was withdrawn based on business-related matters and there are no new safety concerns related to the trial. No patients were enrolled.” (67% match in meaning)
• Medication Use Among American Indians Adults
  “The study has not been stopped. The study does not qualify as a clinical trial so it was withdrawn from clinicaltrials.gov.” (66% match in meaning)
• PD-1, LAG-3 and TIM-3 Checkpoint Blockade in DLBCL
  “Investigator request to no longer pursue this study. Lack of support from drug company. This trial never opened. Withdrew IND.” (66% match in meaning)
• A Dose-ranging Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Low Back Pain
  “Based on lack of efficacy in PAI2003, sponsor made the decision to discontinue the trial.” (66% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.